Regeneron Pharmaceuticals Inc v Alvotech Hf & Anor [2025] EWHC 2623 (Pat) (29 September 2025)
The court grants an expedited trial, finding that both parties' desire for expedition is substantiated and the court can accommodate a short, narrow trial, but the earliest feasible date is 3rd November due to necessary pleadings and preparation, particularly regarding proportionality and delay arguments.
- Citation
- [2025] EWHC 2623 (Pat)
- Parties
- Claimant: Regeneron Pharmaceuticals, Inc.; Defendant: Alvotech Hf.; Defendant: Fisher Clinical Services UK Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 29 September 2025
- Procedural Posture
- Patent Litigation / Application for Expedition
- Outcome
- Application for expedition granted
- Legal Topics
- Expedition of Trial, Injunctions, Proportionality, Delay
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Regeneron Pharmaceuticals, Inc.
Claimant
Alvotech Hf.
Defendant
Fisher Clinical Services UK Limited
Defendant
Procedural Posture
Patent Litigation / Application for Expedition
Legal Issues
- 1 Whether the trial should be expedited
- 2 Whether an injunction, if granted, would be disproportionate due to delay or modest damages
Ratio Decidendi
The court grants an expedited trial, finding that both parties' desire for expedition is substantiated and the court can accommodate a short, narrow trial, but the earliest feasible date is 3rd November due to necessary pleadings and preparation, particularly regarding proportionality and delay arguments.
Court Disposition
Application for expedition granted
Orders
- Trial to be heard on an expedited basis starting 3rd November
- Two days allocated for the hearing
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment